Soliqua 100/33 100 U/mL (Insulin Glargine and Lixisenatide INJECTION, SOLUTION) 100 U/mL

Soliqua 100/33 is a combination of insulin glargine and lixisenatide, designed for subcutaneous administration. This medication is used to manage blood sugar levels in adults with type 2 diabetes. It offers a convenient solution for those requiring dual-action therapy.

Strength

100 U/mL

Pack Size

1 SYRINGE in 1 CARTON (0024-5761-01) / 3 mL in 1 SYRINGE

Manufacturer / TM Owner

Sanofi-Aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Soliqua 100/33 is primarily used for the management of type 2 diabetes in adults. This medication combines insulin glargine, a long-acting insulin, with lixisenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Together, they help control blood sugar levels by improving insulin production and reducing glucose output from the liver. People often ask, 'What is Soliqua 100/33 used for?' It is typically prescribed for individuals who need both basal insulin and GLP-1 receptor agonist therapy.

Side Effects

Common effects of Soliqua 100/33 may include nausea, vomiting, diarrhea, and injection site reactions. Some users may experience hypoglycemia, or low blood sugar, especially when starting the medication or changing doses. It is important to monitor blood sugar levels regularly while using this medication.

Precautions & Warnings

Soliqua 100/33 should be handled with care. Store it in a refrigerator and protect it from light. Always check the solution for particles or discoloration before use. Do not share needles or syringes to prevent infection. Consult a healthcare provider before starting this medication, especially if you have a history of severe gastrointestinal disease or pancreatitis.

Avoid Interactions

Soliqua 100/33 may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol can also affect blood sugar levels and should be consumed with caution. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Soliqua 100/33 is used to manage blood sugar levels in adults with type 2 diabetes. It combines insulin glargine and lixisenatide to provide dual-action therapy.

Soliqua 100/33 is administered subcutaneously, typically in the abdomen, thigh, or upper arm. Always follow the instructions provided by your healthcare provider.

Common side effects may include nausea, vomiting, diarrhea, and injection site reactions. Hypoglycemia can also occur, so regular blood sugar monitoring is important.

Soliqua 100/33 may interact with other diabetes medications. Always consult your healthcare provider before combining it with other treatments.

Soliqua 100/33 should be stored in a refrigerator and protected from light. Do not freeze the medication and always check for particles or discoloration before use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.